Forget Nvidia, Buy This Magnificent Healthcare Stock Instead

26.05.24 14:10 Uhr

Werte in diesem Artikel
Aktien

130,14 EUR 3,80 EUR 3,01%

Indizes

PKT PKT

19.908,9 PKT 6,1 PKT 0,03%

17.862,2 PKT 5,2 PKT 0,03%

5.487,0 PKT 13,8 PKT 0,25%

Nvidia (NASDAQ: NVDA) has been a great stock to own, and it could remain that way for long-term investors. However, the problem is that it's trading at nearly 40 times its future profits. At such a high valuation, it sets a high bar for the business and effectively prices in a lot of future growth already. It could make it difficult for the stock to continue to generate high returns. Even if it does, at such an inflated valuation, the risk of a potential sell-off is high if the business falls short of analyst and investor expectations.There are arguably better opportunities out there for investors than just buying shares of Nvidia. There are magnificent stocks to buy in other industries, such as healthcare, which may provide investors with safer and better overall investment options. One stock that looks particularly attractive right now is AbbVie (NYSE: ABBV).AbbVie hasn't been nearly as hot a buy as Nvidia, and for good reason -- its growth rate has been underwhelming. During the first three months of the year, the company's revenue totaled $12.3 billion and was up less than 1% year over year.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Ausgewählte Hebelprodukte auf NVIDIA

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NVIDIA

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: MotleyFool

Nachrichten zu NVIDIA Corp.

Analysen zu NVIDIA Corp.

DatumRatingAnalyst
17.06.2024NVIDIA OutperformBernstein Research
11.06.2024NVIDIA HaltenDZ BANK
04.06.2024NVIDIA OutperformBernstein Research
03.06.2024NVIDIA BuyGoldman Sachs Group Inc.
03.06.2024NVIDIA BuyUBS AG
DatumRatingAnalyst
17.06.2024NVIDIA OutperformBernstein Research
04.06.2024NVIDIA OutperformBernstein Research
03.06.2024NVIDIA BuyGoldman Sachs Group Inc.
03.06.2024NVIDIA BuyUBS AG
30.05.2024NVIDIA BuyUBS AG
DatumRatingAnalyst
11.06.2024NVIDIA HaltenDZ BANK
23.05.2024NVIDIA HaltenDZ BANK
23.05.2024NVIDIA HoldDeutsche Bank AG
24.08.2023NVIDIA HoldDeutsche Bank AG
29.01.2019NVIDIA UnderperformNeedham & Company, LLC
DatumRatingAnalyst
04.04.2017NVIDIA UnderweightPacific Crest Securities Inc.
24.02.2017NVIDIA UnderperformBMO Capital Markets
23.02.2017NVIDIA ReduceInstinet
14.01.2016NVIDIA UnderweightBarclays Capital
26.07.2011NVIDIA underperformNeedham & Company, LLC

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für NVIDIA Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"